Opinion|Videos|October 18, 2024

Lupus Nephritis Management: Monitoring Strategies and Long-Term Study Results

Key Takeaways

  • Regular assessment of renal function, proteinuria, and serological markers is crucial for monitoring lupus nephritis progression and treatment response.
  • Long-term follow-up data offer valuable insights into the sustained efficacy and safety of lupus nephritis treatments.
SHOW MORE

Panelists discuss the differences in efficacy and safety profiles between belimumab and voclosporin for lupus nephritis (LN) and how payers are evaluating their value, including considerations of cost-effectiveness in LN management.

  • How do you monitor patients with lupus nephritis for disease progression and treatment response? (Dr. Larranaga)
  • Three-year follow-up results of voclosporin from the AURORA-2 study were published earlier this year. What is the value of long-term follow-up data such as these in lupus nephritis? (Dr. Wells)

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.


Latest CME

Brand Logo

259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo